Business Trends– category –
-
Medtronic Spins Off Diabetes Business as MiniMed Group, Reshapes Medtech Strategy with AI and Automation Focus
Stock Titan USA Overview Medtronic is strategically realigning its global medical technology business, completing the spin-off of its diabetes operating unit as 'MiniMed Group, Inc.' through an IPO in March 2026. The company is now shapi... -
Ultrahuman Launches M2 Live Metabolic Health Platform in U.S., Integrating Abbott’s OTC Lingo CGM for Prescription-Free Glucose Tracking
PR Newswire USA Overview Ultrahuman, a smart ring manufacturer, has launched 'M2 Live,' a metabolic health platform in the U.S. that integrates data from Abbott's over-the-counter (OTC) continuous glucose monitor (CGM) 'Lingo.' Available... -
Medtronic Enhances MiniMed 780G AID System with New CGM Sensors and Launches Screenless MiniMed Flex Pump
diaTribe.org USA Overview Medtronic has introduced two new continuous glucose monitor (CGM) sensors for its MiniMed 780G automated insulin delivery (AID) system in the U.S.: the 6-day Simplera Sync and the 15-day Instinct (based on Abbot... -
FDA Clears Dexcom’s Stelo, First Over-the-Counter CGM for Non-Insulin-Using Children Aged Two and Older
FDA USA Overview The U.S. FDA has approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged two and older who do not use insulin. This expansion significantly ... -
Beam Therapeutics Secures FDA IND Clearance for Liver-Targeted LNP Formulation BEAM-304 as PKU Treatment, Phase 1/2 Trial Imminent
Business Wire / Nasdaq USA Overview Beam Therapeutics announced FDA Investigational New Drug (IND) clearance for BEAM-304, its lead candidate for Phenylketonuria (PKU). BEAM-304 is a liver-targeted lipid nanoparticle (LNP) formulated bas... -
Italian DeepTech X-nano Raises €3.7M for Methane-to-Graphite Pilot Plant
Startupbusiness イタリア Overview Italian DeepTech startup X-nano, an IIT spin-off, has secured €3.7 million in seed funding to establish a pilot plant for its non-catalytic methane pyrolysis technology. This investment aims to accelerat... -
Canon Invests ¥50 Billion in New NIL Factory in Japan, Targets 2nm Process to Challenge ASML’s EUV Dominance
Move Silicon Japan Overview Canon is investing ¥50 billion (approximately $320 million USD) in a new lithography equipment factory in Utsunomiya, Japan, to aggressively advance its Nanoimprint Lithography (NIL) technology. The company cl... -
HydroGraph Launches Fractal Graphene Paste to Seamlessly Integrate Graphene into Existing Industrial Products like Cement and Coatings
YouTube (KE Report) USA Overview HydroGraph has introduced a new fractal graphene paste product designed to simplify the integration of graphene into existing industrial products. This user-friendly paste allows for easy incorporation in... -
Orca Bio Expands East Coast Manufacturing Capacity and Triples West Coast Workforce Ahead of Potential Orca-T® Commercial Launch, with FDA PDUFA Date Set for July 6, 2026
Business Wire USA Overview Orca Bio announced significant manufacturing expansions for its investigational cell therapy, Orca-T®, in anticipation of its commercial launch. This includes establishing new East Coast manufacturing capacity ... -
SonoThera Raises $125M Series B to Advance Safer Ultrasound-Mediated Gene Therapies for Duchenne Muscular Dystrophy and ADPKD into Clinical Development
BioSpace USA Overview SonoThera has secured $125 million in Series B financing to advance its gene therapy programs for Duchenne muscular dystrophy (DMD) and autosomal dominant polycystic kidney disease (ADPKD) into clinical development....
